Compliance Claim Guidance Being Considered By FDA - DDMAC's Palmer
Executive Summary
Promotional "compliance claims" may be the next subject tackled in a draft guidance from FDA's Division of Drug Marketing, Advertising & Communications, Branch Chief Leah Palmer told the Drug Information Association annual meeting.
You may also be interested in...
Rx Marketing Needs "Independent Voice" In Washington - AAAA's Kamp
Pharmaceutical marketing groups should consider establishing an "independent voice" to address political issues from the point of view of advertisers, AAAA Senior VP John Kamp told the Healthcare Marketing & Communications Council meeting in Basking Ridge, N.J. May 11.
Rx Marketing Needs "Independent Voice" In Washington - AAAA's Kamp
Pharmaceutical marketing groups should consider establishing an "independent voice" to address political issues from the point of view of advertisers, AAAA Senior VP John Kamp told the Healthcare Marketing & Communications Council meeting in Basking Ridge, N.J. May 11.
Journal Article Scrutiny Increases In Recent FDA Ad Division Letters
FDA is scrutinizing use of published studies in promotional campaigns more closely, recent untitled letters issued by the agency's Division of Drug Marketing, Advertising & Communication indicate.